Researchers have built a compact set of quantitative scores that makes single-cell RNA-seq data more useful for studying breast tumors. Working with public datasets from estrogen receptor–positive, HER2-positive, and triple-negative cancers, the team measured copy number alteration load, transcriptomic entropy, and activity across several protein–protein interaction networks.
The scores pulled out clear biological patterns. High entropy and strong cell-cycle network activity marked clusters with brisk mitotic activity, a feature most evident in triple-negative samples. Copy number alteration profiles differed by subtype and tracked closely with both entropy and the two interaction networks linked to basal and mesenchymal programs. Together, the four metrics separated cell populations within each tumor as well as differences among subtypes, capturing variation that would be missed by marker genes alone.
Because the method works at single-cell resolution, it spots rare clones and emerging cell states that bulk sequencing cannot catch. The authors suggest that mapping these quantitative traits across time or treatment could point to escape routes that tumors use during therapy, and that the same framework can be dropped into any single-cell dataset without extra wet-lab steps. Their code and reference tables are available online.
With a brief list of inputs, the approach brings order to the noisy world of tumor heterogeneity and offers a practical path toward more tailored experimental and clinical studies.
Publication Details
Senra D, Guisoni N, Diambra L. Unraveling Tumor Heterogeneity: Quantitative Insights from Single-cell RNA Sequencing Analysis in Breast Cancer Subtypes. Gene Expr. Published online: Apr 25, 2025. doi: 10.14218/GE.2024.00071.
The scores pulled out clear biological patterns. High entropy and strong cell-cycle network activity marked clusters with brisk mitotic activity, a feature most evident in triple-negative samples. Copy number alteration profiles differed by subtype and tracked closely with both entropy and the two interaction networks linked to basal and mesenchymal programs. Together, the four metrics separated cell populations within each tumor as well as differences among subtypes, capturing variation that would be missed by marker genes alone.
Because the method works at single-cell resolution, it spots rare clones and emerging cell states that bulk sequencing cannot catch. The authors suggest that mapping these quantitative traits across time or treatment could point to escape routes that tumors use during therapy, and that the same framework can be dropped into any single-cell dataset without extra wet-lab steps. Their code and reference tables are available online.
With a brief list of inputs, the approach brings order to the noisy world of tumor heterogeneity and offers a practical path toward more tailored experimental and clinical studies.
Publication Details
Senra D, Guisoni N, Diambra L. Unraveling Tumor Heterogeneity: Quantitative Insights from Single-cell RNA Sequencing Analysis in Breast Cancer Subtypes. Gene Expr. Published online: Apr 25, 2025. doi: 10.14218/GE.2024.00071.